Coloplast A/S (CPH:COLO.B)
Denmark · Delayed Price · Currency is DKK 612.00
+6.40 (1.06%)
Oct 24, 2025, 9:44 AM CET
Coloplast Market Cap
Coloplast has a market cap or net worth of 136.36 billion as of October 23, 2025. Its market cap has decreased by -29.73% in one year.
Market Cap
136.36B
Enterprise Value
159.85B
Revenue
27.87B
Ranking
n/a
PE Ratio
33.51
Stock Price
612.00
Market Cap Chart
Since November 17, 1997, Coloplast's market cap has increased from 5.88B to 136.36B, an increase of 2,219.07%. That is a compound annual growth rate of 11.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2025 | 135.64B | -23.37% |
| Dec 30, 2024 | 177.00B | 2.05% |
| Dec 29, 2023 | 173.44B | 0.54% |
| Dec 30, 2022 | 172.51B | -29.57% |
| Dec 30, 2021 | 244.93B | 23.89% |
| Dec 30, 2020 | 197.71B | 12.62% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.52T |
| Genmab | 119.29B |
| Demant | 50.10B |
| ALK-Abelló | 47.78B |
| H. Lundbeck | 43.89B |
| Zealand Pharma | 32.72B |
| Ambu A/S | 28.53B |
| Bavarian Nordic | 18.91B |